Team
NGB Platform Registration
Login
Team
NGB Platform Registration
Login
Therapeutic Area: Autoimmune Cytopenias
All Technologies
Clear filters
Opportunity Filters
Off-the-Shelf Allogeneic CAR γδ T-Cell Platform
therapeutic area
Autoimmune Cytopenias
tecnology area
Gene Therapy & Genome Engineering
August 23, 2026
Novel Protein to Promote Nerve Regeneration
therapeutic area
Autoimmune Cytopenias
tecnology area
Gene Therapy & Genome Engineering
August 21, 2026
Modulating the Tumor Immune Microenvironment via Targeting Regulatory Cells (TREGS) with Chimeric Antigen Receptor (CAR) T Cell Therapy
therapeutic area
Autoimmune Cytopenias
tecnology area
Gene Therapy & Genome Engineering
August 21, 2026
Artificial mtDNA Delivery for Age-related Disease
therapeutic area
Autoimmune Cytopenias
tecnology area
Gene Therapy & Genome Engineering
August 21, 2026
Opportunity Filters
IP Status ->
Development Stage ->
Technology Area ->
Therapeutic Area ->
Opportunity Type ->
IP Status
IP Status Not Disclosed
(
0
)
No Patent Filed
(
0
)
Patent Application Filed / Pending
(
0
)
Patent Granted — Active
(
0
)
Development Stage
Late Clinical Development — Diagnostics
(
0
)
Clinical Validation
(
0
)
Preclinical Development
(
0
)
Preclinical — in vivo
(
0
)
Technology Area
Gene Therapy & Genome Engineering
(
0
)
Therapeutic Area
Immunology & Autoimmune Disease
(
0
)
Autoimmune Cytopenias
(
0
)
Pulmonology
(
0
)
Opportunity Type
Clinical Collaboration
(
0
)
Licensing
(
0
)
Market Entry Partnership
(
0
)
view results
Remove filters
Close
Request Information
Subject
*
Message
*
Submit
Insert/edit link
Close
Enter the destination URL
URL
Link Text
Open link in a new tab
Or link to existing content
Search
No search term specified. Showing recent items.
Search or use up and down arrow keys to select an item.
Cancel
